Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05619211 · ClinicalTrials.gov registry record · Phase 1

Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities

A Phase 1 study of Cerebral Palsy, sponsored by University of Alabama at Birmingham.

Completed
Registry status
Phase 1
Development phase
42
Enrollment target
1
Study location

NCT05619211: Completed Phase 1 study of Cerebral Palsy, sponsored by University of Alabama at Birmingham.

NCT05619211 is a Phase 1 study of Cerebral Palsy that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 42 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05619211, a Phase 1 study of Cerebral Palsy, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
Phase 1
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

This study is investigating the potential effects of a high-intensity home-exercise program among children with cerebral palsy. The program includes rhythmic movements to music that are adapted for wheelchair uses and age-appropriate themes. This project has the potential to address a large knowledge gap in the extant literature, because there are no widely accessible, evidence-based, enjoyable, and age-appropriate modalities for improving cardiovascular fitness or cardiometabolic health among children with disabilities who have mobility disabilities.

Primary Outcome

peak oxygen consumption (mL/kg-1/min-1) obtained from a graded exercise test on an arm ergometer. Data represents the child participant. Outcome measures were not collected for the parent participant.

Conditions Studied

Interventions

  • BEHAVIORAL Sprint-Intensity Interval Training with Telecoaching

Study Locations (1)

Alabama

  • Wellness Health And Research Facility (WHARF) - Homewood

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2023-09-29
Est. Completion 2025-12-18
Phase Phase 1
University of Alabama at Birmingham

1,160 total trials

What the finished NCT05619211 record still lists

NCT05619211 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (82% lower).

The record links to 1 condition, with Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which Sprint-Intensity Interval Training with Telecoaching is the first listed.

NCT05619211 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT05619211 about?

NCT05619211 is a clinical study titled "Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities". This study is investigating the potential effects of a high-intensity home-exercise program among children with cerebral palsy. The program includes rhythmic movements to music that are adapted for wheelchair uses and age-appropriate themes. This project has the potential to address a large knowledg...

What is the current status of trial NCT05619211?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2023-09-29. Estimated completion is 2025-12-18.

What conditions does trial NCT05619211 study?

This clinical trial studies the following conditions: Cerebral Palsy.

What interventions are being tested in trial NCT05619211?

The interventions under investigation include: Sprint-Intensity Interval Training with Telecoaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT05619211?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05619211 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05619211's enrollment target sits among peer trials

42 43rd of 91 higher than 49 of 91 other Cerebral Palsy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05619211, the US trial registry maintained by the National Library of Medicine. NCT05619211 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.